The ideal nasal corticosteroid: Balancing efficacy, safety and patient preference

Clinical and Experimental Allergy Reviews

Volumn 2, Issue 1, 2002, Pages 32-37

  Durham, S R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Allergic inflammation; Allergic rhinitis; Intranasal corticosteroids; Triamcinolone acetonide (TAA)

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE DIPROPIONATE; CETIRIZINE; CHROMONE DERIVATIVE; CORTICOSTEROID; CYTOKINE; LONG ACTING DRUG; TRIAMCINOLONE ACETONIDE;

ADRENAL CORTEX FUNCTION; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; BLEEDING; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRY SKIN; EPISTAXIS; GROWTH RETARDATION; HUMAN; MAST CELL; MUCOSA INFLAMMATION; NOSE CONGESTION; NOSE MUCOSA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEASONAL VARIATION; SKIN IRRITATION; T LYMPHOCYTE; TH2 CELL; TREATMENT OUTCOME;

EID: 0036424950     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2002.00032.x     Document Type: Article

References (29)

1. Durham S, Ying S, Varney V et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992; 148:2390-5.
2. Varney VA, Jacobson MR, Sudderick RM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992; 146:170-6.
3. Morikawa H, Nagashima S. The role of costimulatory molecules (B7-1 and B7-2) on allergen-stimulated B cells in cedar pollinosis subjects. Clin Exp Allergy 2000; 30:383-92.
4. Nakada M, Nishizaki K, Yoshino T et al. CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions. J Allergy Clin Immunol 1999; 104:222-7.
5. Sato J, Asakura K, Murakami M et al. Topical CTLA4-Ig suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis. Int Arch Allergy Immunol 1999; 119:197-204.
6. Till SJ, Jacobson MR, O'Brien F et al. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy 2001; 56:126-31.
7. Masuyama K, Till SJ, Jacobson MR et al. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids. J Allergy Clin Immunol 1998; 102:610-7.
8. Cameron LA, Durham SR, Jacobson MR et al. Expression of IL-4, C-epsilon RNA, and L-epsilon RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids. J Allergy Clin Immunol 1998; 101:330-6.
9. Durham SR, Gould H J, Thienes CP et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997; 27:2899-906.
10. van Cauwenberge P, Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000; 55:116-34.
11. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989; 83:627-33.
12. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 1998; 317:1624-9.
13. Welsh PW, Stricker WE, Chu CP et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987; 62:125-34.
14. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone diproprionate nasal spray: Regular versus 'as required' use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1990; 86:380-6.
15. Dunn AM, Wilson RS, Baggott PJ. A comparison of beclomethasone dipropionate aqueous nasal spray and beclomethasone dipropionate pressurized nasal spray in the management of seasonal rhinitis. Postgrad Med J 1984; 60:404-6.
16. Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993; 82:635-40
17. Skoner DP, Rachelefsky GS, Meltzer EO et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000; 105:E23-9.
18. Michels MI, Smith RE, Heimlich EM. Adrenal suppression and intranasally applied steroids. Ann Allergy 1967; 25:569-74.
19. Turkeltaub PC, Norman PS, Johnson JD, Crepea S. Treatment of seasonal and perennial rhinitis with intranasal flunisolide. Allergy 1982; 37:303-11.
20. Spector S, Bronsky E, Chervinsky P et al. Multicenter, doubleblind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy 1990; 64:300-5.
21. Orgel HA, Meltzer EO, Bierman CW et al. Intranasal fluocortin butyl in patients with perennial rhinitis: A 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol 1991; 88:257-64.
22. Grossman J, Banov C, Bronsky EA et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993; 92:594-9.
23. Schenkel EJ, Gross G, Jacobson K, Kobayashi RH, Settipane G. Triamcinolone acetonide aqueous nasal inhaler for the treatment of spring grass seasonal allergic rhinitis in children. Pediatr Allergy Immunol 1997; 11:129-36.
24. Kobayashi RH, Beaucher WN, Koepke JW et al. Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 1995; 17:503-13.
25. Fishken D. Patient preference and sensory comparisons of Nasacort AQ Beconase and Flonase. Abstracts presented at the 1996 Annual Meeting ACAAI. Ann Allergy Asthma Immunol 1997; 78:604-20. (Abstract)
26. Laliberte F, Laliberte MF, Lecart S et al. Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group. Allergy 2000; 55:718-22.
27. Skoner D, Kane R, Stamatiadis D et al. Triamcinolone acetonide aqueous nasal inhaler and fluticasone propionate have no effect on short-term growth in children with allergic rhinitis. Allergy 2000; 55 (Suppl. 63):184.
28. Howland WC, Dockhorn R, Gillman S et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol 1996; 98:32-8.
29. Nayak AS, Ellis MH, Gross GN et al. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis. J Allergy Clin Immunol 1998; 101:157-62.